Literature DB >> 26383234

Mechanisms underlying the formation of induced pluripotent stem cells.

Federico González1, Danwei Huangfu1.   

Abstract

Human pluripotent stem cells (hPSCs) offer unique opportunities for studying human biology, modeling diseases, and therapeutic applications. The simplest approach so far to generate human PSC lines is through reprogramming of somatic cells from an individual by defined factors, referred to simply as reprogramming. Reprogramming circumvents the ethical controversies associated with human embryonic stem cells (hESCs) and nuclear transfer hESCs (nt-hESCs), and the resulting induced pluripotent stem cells (hiPSCs) retain the same basic genetic makeup as the somatic cell used for reprogramming. Since the first report of iPSCs by Takahashi and Yamanaka (Cell 2006, 126:663-676), the molecular mechanisms of reprogramming have been extensively investigated. A better mechanistic understanding of reprogramming is fundamental not only to iPSC biology and improving the quality of iPSCs for therapeutic use, but also to our understanding of the molecular basis of cell identity, pluripotency, and plasticity. Here, we summarize the genetic, epigenetic, and cellular events during reprogramming, and the roles of various factors identified thus far in the reprogramming process. WIREs Dev Biol 2016, 5:39-65. doi: 10.1002/wdev.206 For further resources related to this article, please visit the WIREs website.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26383234      PMCID: PMC4715477          DOI: 10.1002/wdev.206

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Dev Biol        ISSN: 1759-7684            Impact factor:   5.814


  229 in total

Review 1.  Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins.

Authors:  Leonie Ringrose; Renato Paro
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

2.  Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

Authors:  Bjarki Johannesson; Ido Sagi; Athurva Gore; Daniel Paull; Mitsutoshi Yamada; Tamar Golan-Lev; Zhe Li; Charles LeDuc; Yufeng Shen; Samantha Stern; Nanfang Xu; Hong Ma; Eunju Kang; Shoukhrat Mitalipov; Mark V Sauer; Kun Zhang; Nissim Benvenisty; Dieter Egli
Journal:  Cell Stem Cell       Date:  2014-11-06       Impact factor: 24.633

3.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.

Authors:  Jiekai Chen; He Liu; Jing Liu; Jing Qi; Bei Wei; Jiaqi Yang; Hanquan Liang; You Chen; Jing Chen; Yaran Wu; Lin Guo; Jieying Zhu; Xiangjie Zhao; Tianran Peng; Yixin Zhang; Shen Chen; Xuejia Li; Dongwei Li; Tao Wang; Duanqing Pei
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

4.  The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation.

Authors:  Chengqi Lin; Alexander S Garruss; Zhuojuan Luo; Fengli Guo; Ali Shilatifard
Journal:  Cell       Date:  2012-12-27       Impact factor: 41.582

5.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

6.  Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells.

Authors:  Judith Staerk; Costas A Lyssiotis; Lea A Medeiro; Michael Bollong; Ruth K Foreman; Shoutian Zhu; Michael Garcia; Qing Gao; Laure C Bouchez; Luke L Lairson; Bradley D Charette; Lubica Supekova; Jeffrey Janes; Achim Brinker; Charles Y Cho; Rudolf Jaenisch; Peter G Schultz
Journal:  Angew Chem Int Ed Engl       Date:  2011-05-05       Impact factor: 15.336

7.  Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.

Authors:  Claudia A Doege; Keiichi Inoue; Toru Yamashita; David B Rhee; Skylar Travis; Ryousuke Fujita; Paolo Guarnieri; Govind Bhagat; William B Vanti; Alan Shih; Ross L Levine; Sara Nik; Emily I Chen; Asa Abeliovich
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

Review 8.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application.

Authors:  Gaoyang Liang; Yi Zhang
Journal:  Cell Stem Cell       Date:  2013-08-01       Impact factor: 24.633

9.  Derivation of naive human embryonic stem cells.

Authors:  Carol B Ware; Angelique M Nelson; Brigham Mecham; Jennifer Hesson; Wenyu Zhou; Erica C Jonlin; Antonio J Jimenez-Caliani; Xinxian Deng; Christopher Cavanaugh; Savannah Cook; Paul J Tesar; Jeffrey Okada; Lilyana Margaretha; Henrik Sperber; Michael Choi; C Anthony Blau; Piper M Treuting; R David Hawkins; Vincenzo Cirulli; Hannele Ruohola-Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-12       Impact factor: 11.205

10.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

View more
  7 in total

1.  TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition.

Authors:  Yuan Wang; Shuang Chen; Qingyuan Jiang; Jie Deng; Fuyi Cheng; Yi Lin; Lin Cheng; Yixin Ye; Xiaolei Chen; Yunqi Yao; Xiaomei Zhang; Gang Shi; Lei Dai; Xiaolan Su; Yong Peng; Hongxin Deng
Journal:  Cell Death Dis       Date:  2020-06-25       Impact factor: 8.469

2.  Regulating glioma stem cells by hypoxia through the Notch1 and Oct3/4 signaling pathway.

Authors:  Fei Zeng; Hong Chen; Zhaohui Zhang; Tao Yao; Guan Wang; Qingxing Zeng; Shenhan Duan; Yanqiang Zhan
Journal:  Oncol Lett       Date:  2018-09-17       Impact factor: 2.967

3.  Exogenous human OKSM factors maintain pluripotency gene expression of bovine and porcine iPS-like cells obtained with STEMCCA delivery system.

Authors:  Jesica R Canizo; Camila Vazquez Echegaray; Doris Klisch; Juan F Aller; Dante A Paz; Ricardo H Alberio; Ramiro Alberio; Alejandra S Guberman
Journal:  BMC Res Notes       Date:  2018-07-27

4.  NANOG and LIN28 dramatically improve human cell reprogramming by modulating LIN41 and canonical WNT activities.

Authors:  Ling Wang; Yue Su; Chang Huang; Yexuan Yin; Alexander Chu; Alec Knupp; Young Tang
Journal:  Biol Open       Date:  2019-12-05       Impact factor: 2.422

5.  Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.

Authors:  Sergiy Velychko; Kenjiro Adachi; Kee-Pyo Kim; Yanlin Hou; Caitlin M MacCarthy; Guangming Wu; Hans R Schöler
Journal:  Cell Stem Cell       Date:  2019-11-07       Impact factor: 24.633

6.  Dppa2/4 Facilitate Epigenetic Remodeling during Reprogramming to Pluripotency.

Authors:  Charles Hernandez; Zheng Wang; Bulat Ramazanov; Yin Tang; Sameet Mehta; Cheryl Dambrot; Yu-Wei Lee; Kaleab Tessema; Ishan Kumar; Michael Astudillo; Thomas A Neubert; Shangqin Guo; Natalia B Ivanova
Journal:  Cell Stem Cell       Date:  2018-08-23       Impact factor: 24.633

7.  Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.

Authors:  Adekunle Ebenezer Omole; Adegbenro Omotuyi John Fakoya
Journal:  PeerJ       Date:  2018-05-11       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.